JOINT FILING AGREEMENT
EXHIBIT 99.1
The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock of Navidea Biopharmaceuticals, Inc. dated as of March 8, 2016 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: March 9, 2016
| PLATINUM PARTNERS VALUE ARBITRAGE FUND L.P. | ||||
| By: | Platinum Management (NY) LLC, as Investment Manager | |||
| By: | /s/ Xxxxxx XxxXxxxxxx | |||
| Name: | Xxxxxx XxxXxxxxxx | |||
| Title: | Chief Financial Officer | |||
| PLATINUM MANAGEMENT (NY) LLC | ||||
| By: | /s/ Xxxxxx XxxXxxxxxx | |||
| Name: | Xxxxxx XxxXxxxxxx | |||
| Title: | Chief Financial Officer | |||
| PLATINUM PARTNERS LIQUID OPPORTUNITY MASTER FUND LP | ||||
| By: | Platinum Liquid Opportunity Management (NY) LLC, as Investment Manager | |||
| By: | /s/ Xxxxxx XxxXxxxxxx | |||
| Name: | Xxxxxx XxxXxxxxxx | |||
| Title: | Chief Financial Officer | |||
| PLATINUM LIQUID OPPORTUNITY MANAGEMENT (NY) LLC | ||||
| By: | /s/ Xxxxxx XxxXxxxxxx | |||
| Name: | Xxxxxx XxxXxxxxxx | |||
| Title: | Chief Financial Officer | |||
| /s/ Xxxx Xxxxxxxxx |
| XXXX XXXXXXXXX |
